Colistin pharmacokinetics: the fog is lifting

Authors


W. Couet, INSERM ERI 23, Pôle Biologie Santé (PBS), Médecine-Sud, Niveau 1, 1 rue Georges Bonnet, 86022 Poitiers Cedex, France
E-mail:william.couet@univ-poitiers.fr

Abstract

Clin Microbiol Infect 2012; 18: 30–39

Abstract

Colistin is a re-emerging old antibiotic that is used to treat multidrug-resistant infections in critically ill patients. It corresponds to a mixture of at least 30 different compounds administered as inactive derivatives. Therefore, colistin pharmacokinetics are quite difficult to investigate and complex to predict. However specific chromatographic methods have been made available in recent years, leading to a series of modern pharmacokinetic studies after intravenous administration of the prodrug to critical-care patients; these have been conducted by a few groups and have only been recently published. The objective of this article was to conduct a critical review of these very informative modern pharmacokinetic studies and to provide prospective thoughts.

Ancillary